However, HER2-positive breast cancer patients with HR-negative status, T3 (cT > 5 cm), or histological grade 3 might achieve a higher pCR rate [Odds ratio (OR) > 2] with the TCbIP regimen compared to TCbHP. Here, ERBB2 is linked to breast cancer.